Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy P Sheahan

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|August 13, 2024
Disparate SARS-CoV-2 infection outcomes abound, but what makes SARS-CoV-2 bound for rebound?Timothy P Sheahan
Gastroenterology|November 2, 2013
Single cell analysis of HCV-infected patient hepatocytes: the science is no longer science fictionTimothy P Sheahan, Charles M Rice
Future Virology|December 15, 2018
Is regulation preventing the development of therapeutics that may prevent future coronavirus pandemics?Timothy P Sheahan, Ralph S Baric
Current Opinion in Virology|June 23, 2020
The continued epidemic threat of SARS-CoV-2 and implications for the future of global public healthTimothy P Sheahan, Matthew B Frieman
Plos One|July 25, 2019
Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysisSarah R Leist, Kara L Jensen, Ralph S Baric, et al.
Annual Review of Virology|April 21, 2015
New Methods in Tissue Engineering: Improved Models for Viral InfectionVyas Ramanan, Margaret A Scull, Timothy P Sheahan, et al.
Bio-Protocol|April 2, 2021
Primer ID Next-Generation Sequencing for the Analysis of a Broad Spectrum Antiviral Induced Transition Mutations and Errors Rates in a Coronavirus GenomeShuntai Zhou, Collin S Hill, Michael U Clark, et al.
Virus Research|November 28, 2023
A nano-luciferase expressing human coronavirus OC43 for countermeasure developmentMeghan V Diefenbacher, Thomas J Baric, David R Martinez, et al.
Mbio|March 17, 2021
Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and ReplicationLily E Adams, Kenneth H Dinnon, Yixuan J Hou, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 9, 2020
A mechanism-based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID-19 treatment in humansPatrick O Hanafin, Brian Jermain, Anthony J Hickey, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|August 13, 2024
Disparate SARS-CoV-2 infection outcomes abound, but what makes SARS-CoV-2 bound for rebound?Timothy P Sheahan
Gastroenterology|November 2, 2013
Single cell analysis of HCV-infected patient hepatocytes: the science is no longer science fictionTimothy P Sheahan, Charles M Rice
Future Virology|December 15, 2018
Is regulation preventing the development of therapeutics that may prevent future coronavirus pandemics?Timothy P Sheahan, Ralph S Baric
Current Opinion in Virology|June 23, 2020
The continued epidemic threat of SARS-CoV-2 and implications for the future of global public healthTimothy P Sheahan, Matthew B Frieman
Plos One|July 25, 2019
Increasing the translation of mouse models of MERS coronavirus pathogenesis through kinetic hematological analysisSarah R Leist, Kara L Jensen, Ralph S Baric, et al.
Annual Review of Virology|April 21, 2015
New Methods in Tissue Engineering: Improved Models for Viral InfectionVyas Ramanan, Margaret A Scull, Timothy P Sheahan, et al.
Bio-Protocol|April 2, 2021
Primer ID Next-Generation Sequencing for the Analysis of a Broad Spectrum Antiviral Induced Transition Mutations and Errors Rates in a Coronavirus GenomeShuntai Zhou, Collin S Hill, Michael U Clark, et al.
Virus Research|November 28, 2023
A nano-luciferase expressing human coronavirus OC43 for countermeasure developmentMeghan V Diefenbacher, Thomas J Baric, David R Martinez, et al.
Mbio|March 17, 2021
Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and ReplicationLily E Adams, Kenneth H Dinnon, Yixuan J Hou, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 9, 2020
A mechanism-based pharmacokinetic model of remdesivir leveraging interspecies scaling to simulate COVID-19 treatment in humansPatrick O Hanafin, Brian Jermain, Anthony J Hickey, et al.
Pageof 9